retatrutide clinical status ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Retatrutide Significantly Reduces Visceral Fat

Claims of significant weight loss from these products arent supported by scientific research

Thomsen RW, Mailhac A, Lhde JB, Pottegrd A

Conclusions and Future Perspectives Overall, GLP-1RAs are considered novel blood glucose lowering drugs used in the treatment of T2MD (229), owing to their advantages of lowering blood pressure, lowering the levels of fasting blood glucose, lowering HbA1c, inducing weight loss, and being associated with a low incidence of hypoglycemia

Zero Sugar, Carbs or Calories

Certain red flags require prompt medical evaluation

Before each workout, coaches check in on how you're feeling and adjust intensity, load, and volume in real time based on your energy that day